2m 2m 2m 2m 2m 2m 2m
ANI Pharmaceutic (ANIP)
NASDAQ
$83.65+$0.70 (+0.85%)
Price as of Jun 23, 2026 5:36 PM EDT- $1.8BMarket Cap
- 23.83%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ANI Pharmaceutic (ANIP)
$83.65+$0.70 (+0.85%)
ANIP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $82.94 | ||
Change | +$2.36 (+2.93%) | ||
Open | $81.31 | ||
High | $83.31 | ||
Low | $80.62 | ||
Previous Close | $80.58 | ||
Volume | 378,058 | ||
30-Day Average Volume | 324,143 | ||
1-Week Change | -0.07% | ||
1-Month Change | 0.27% | ||
1-Year Change | 23.83% | ||
3-Year Change | 60.33% | ||
5-Year Change | 152.25% | ||
Fundamentals | |||
Shares Outstanding | 22.7M | ||
Total Assets | $1.4B | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $237.5M | ||
Net Income | $29.5M | ||
Free Cash Flow | $52.3M | ||
EBIT | $44.0M | ||
EBITDA | $64.9M | ||
Net Working Capital | $507.6M | ||
EPS | $1.28 | ||
Enterprise Value/EBITDA | 28 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 3 | ||
P/E | 63 | ||
PEG | 7 | ||
Price/Free Cash Flow | 35 | ||
Price/Operating Cash Flow | 31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 06/04/2012 | ||
Earnings & Revenue